E26 refers to Hyperaldosteronism, a broad class of endocrine disorders involving the parathyroid, pituitary, adrenal, thymus, gonads, and other hormone-producing glands. These conditions may cause hormone excess or deficiency and affect growth, metabolism, reproduction, and immune regulation.
Diagnosis of Hyperaldosteronism involves hormone panels (cortisol, ACTH, TSH, LH/FSH, aldosterone, calcium), stimulation or suppression testing, imaging (CT/MRI of glands), genetic testing, and physical examination. The exact workup depends on the suspected gland and hormone axis affected.
ICD10 code E26 is used across endocrinology, pediatrics, internal medicine, and reproductive health to classify and manage endocrine gland disorders. It supports hormone therapy decisions, surgical intervention, reproductive planning, and chronic disease monitoring.
Q1: What is ICD10 code E26?
A: This code classifies Hyperaldosteronism, a disorder involving hormone-producing glands that regulate key physiological functions.
Q2: What causes these endocrine disorders?
A: Causes include tumors, autoimmune disease, genetic syndromes, trauma, or idiopathic dysfunction.
Q3: Are these conditions curable?
A: Some are treatable with hormone replacement or surgery; others require lifelong hormone regulation.
Q4: What are common treatments?
A: Hormone supplementation or suppression, surgery, radiotherapy, lifestyle changes, or genetic counseling.
Q5: Who manages these disorders?
A: Endocrinologists are primary, with support from reproductive specialists, pediatricians, neurologists, or surgeons depending on the gland involved.
ICD10 code E26 ensures the precise documentation of Hyperaldosteronism. It helps clinicians tailor hormone management strategies, coordinate interdisciplinary care, and track long-term outcomes for a wide range of endocrine-related conditions.
Get started for $0 – no credit card needed. You'll get up to 20 sessions free.
Start Free Trial